Skip to content

I
t
'
s
h
e
r
e
.
Universal
AAV
Immuno-
Gene
Therapy
for
C
a
n
c
e
r

Changing the game to help cancer patients win

At Siren, we are combining the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single, powerful new treatment modality to fight cancer.

Our Vision

For AAV immuno-gene therapy to be the cornerstone treatment for any solid tumor

Brain and Eye Cancer: An Ideal Initial Setting

Brain and eye tumors are our first stop en route to re-inventing solid tumor cancer therapy overall. These are devastating diseases with limited treatment options.

Our AAV immuno-gene therapy is designed to overcome key challenges that have caused past therapies to fail. We are completely reimagining how to treat these cancers.

Together we are sounding the alarm against cancer!

We have the scientific expertise, motivation, and passion to tackle key challenges, solve big problems, and deliver on the massive potential of AAV immuno-gene therapy for patients.

Meet The Team

Cancer is a formidable foe. But we are up to the challenge.

Excited to join us?

Open Positions